T2 Alpha
Payments companies reported to CMS as associated with T2 Alpha. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with T2 Alpha, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with T2 Alpha
These are the largest totals companies reported as associated with T2 Alpha. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| John Scolaro | Orange, CA | Orthopaedic Trauma | $52,856.72 |
| Justin Haller | Salt Lake City, UT | Orthopaedic Trauma | $45,116.23 |
| Hans Vanlancker | Cambridge, MA | Orthopaedic Surgery | $43,817.55 |
| Armodios Hatzidakis | Denver, CO | Adult Reconstructive Orthopaedic Surgery | $41,402.15 |
| David Forsh | New York, NY | Orthopaedic Surgery | $40,319.78 |
| Timothy Achor | Houston, TX | Orthopaedic Trauma | $38,700.06 |
| Sanjit Konda | New York, NY | Orthopaedic Surgery | $37,243.64 |
| Anthony Sorkin | Indianapolis, IN | Orthopaedic Trauma | $36,470.03 |
| Stephen Warner | Houston, TX | Orthopaedic Trauma | $31,612.95 |
| George Ochenjele | Cleveland, OH | Orthopaedic Trauma | $28,598.27 |
Prescribed T2 Alpha?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.